▶ 調査レポート

ENT疾患治療の世界市場（～2026年）
• 英文タイトル：Global ENT Disorder Treatment Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。ENT疾患治療の世界市場（～2026年） / Global ENT Disorder Treatment Market Size, Status and Forecast 2020-2026 / MRC2-11QY11841資料のイメージです。• レポートコード：MRC2-11QY11841
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療、製薬
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Multi User￥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当調査資料はENT疾患治療のグローバル市場について調査・分析したレポートです。種類別（扁桃炎、耳感染症、副鼻腔感染症、睡眠時無呼吸）市場規模、用途別（病院、クリニック、外来手術センター、在宅介護施設、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別ENT疾患治療の競争状況、市場シェア
・世界のENT疾患治療市場：種類別市場規模 2015年-2020年（扁桃炎、耳感染症、副鼻腔感染症、睡眠時無呼吸）
・世界のENT疾患治療市場：種類別市場規模予測 2021年-2026年（扁桃炎、耳感染症、副鼻腔感染症、睡眠時無呼吸）
・世界のENT疾患治療市場：用途別市場規模 2015年-2020年（病院、クリニック、外来手術センター、在宅介護施設、その他）
・世界のENT疾患治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、外来手術センター、在宅介護施設、その他）
・北米のENT疾患治療市場分析：米国、カナダ
・ヨーロッパのENT疾患治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのENT疾患治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のENT疾患治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのENT疾患治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：AstraZeneca、Novartis、Pfizer、Mylan、Teva Pharmaceutical、GlaxoSmithKline、Otonomy、Merck、Reddy’s、Allergen
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

ENT is a medical abbreviation for ears, nose and throat.
Major factor contributing to growth of the global ENT disorder treatment market includes increasing pollution.

Market Analysis and Insights: Global ENT Disorder Treatment Market
The global ENT Disorder Treatment market size is projected to reach US$ 7124.5 million by 2026, from US$ 6930.3 million in 2020, at a CAGR of 2.6%% during 2021-2026.

Global ENT Disorder Treatment Scope and Market Size
ENT Disorder Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global ENT Disorder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
AstraZeneca
Novartis
Pfizer
Mylan
Teva Pharmaceutical
GlaxoSmithKline
Otonomy
Merck
Reddy’s
Allergen

Market segment by Type, the product can be split into
Tonsillitis
Ear Infections
Sinus Infections
Sleep Apnea
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by ENT Disorder Treatment Revenue
1.4 Market by Type
1.4.1 Global ENT Disorder Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Tonsillitis
1.4.3 Ear Infections
1.4.4 Sinus Infections
1.4.5 Sleep Apnea
1.5 Market by Application
1.5.1 Global ENT Disorder Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Home Care Settings
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global ENT Disorder Treatment Market Perspective (2015-2026)
2.2 Global ENT Disorder Treatment Growth Trends by Regions
2.2.1 ENT Disorder Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 ENT Disorder Treatment Historic Market Share by Regions (2015-2020)
2.2.3 ENT Disorder Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 ENT Disorder Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key ENT Disorder Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top ENT Disorder Treatment Players by Market Size
3.1.1 Global Top ENT Disorder Treatment Players by Revenue (2015-2020)
3.1.2 Global ENT Disorder Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global ENT Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global ENT Disorder Treatment Market Concentration Ratio
3.2.1 Global ENT Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by ENT Disorder Treatment Revenue in 2019
3.3 ENT Disorder Treatment Key Players Head office and Area Served
3.4 Key Players ENT Disorder Treatment Product Solution and Service
3.5 Date of Enter into ENT Disorder Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global ENT Disorder Treatment Historic Market Size by Type (2015-2020)
4.2 Global ENT Disorder Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global ENT Disorder Treatment Market Size by Application (2015-2020)
5.2 Global ENT Disorder Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America ENT Disorder Treatment Market Size (2015-2020)
6.2 ENT Disorder Treatment Key Players in North America (2019-2020)
6.3 North America ENT Disorder Treatment Market Size by Type (2015-2020)
6.4 North America ENT Disorder Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe ENT Disorder Treatment Market Size (2015-2020)
7.2 ENT Disorder Treatment Key Players in Europe (2019-2020)
7.3 Europe ENT Disorder Treatment Market Size by Type (2015-2020)
7.4 Europe ENT Disorder Treatment Market Size by Application (2015-2020)

8 China
8.1 China ENT Disorder Treatment Market Size (2015-2020)
8.2 ENT Disorder Treatment Key Players in China (2019-2020)
8.3 China ENT Disorder Treatment Market Size by Type (2015-2020)
8.4 China ENT Disorder Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan ENT Disorder Treatment Market Size (2015-2020)
9.2 ENT Disorder Treatment Key Players in Japan (2019-2020)
9.3 Japan ENT Disorder Treatment Market Size by Type (2015-2020)
9.4 Japan ENT Disorder Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia ENT Disorder Treatment Market Size (2015-2020)
10.2 ENT Disorder Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia ENT Disorder Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia ENT Disorder Treatment Market Size by Application (2015-2020)

11 India
11.1 India ENT Disorder Treatment Market Size (2015-2020)
11.2 ENT Disorder Treatment Key Players in India (2019-2020)
11.3 India ENT Disorder Treatment Market Size by Type (2015-2020)
11.4 India ENT Disorder Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America ENT Disorder Treatment Market Size (2015-2020)
12.2 ENT Disorder Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America ENT Disorder Treatment Market Size by Type (2015-2020)
12.4 Central & South America ENT Disorder Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 AstraZeneca
13.1.1 AstraZeneca Company Details
13.1.2 AstraZeneca Business Overview
13.1.3 AstraZeneca ENT Disorder Treatment Introduction
13.1.4 AstraZeneca Revenue in ENT Disorder Treatment Business (2015-2020))
13.1.5 AstraZeneca Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis ENT Disorder Treatment Introduction
13.2.4 Novartis Revenue in ENT Disorder Treatment Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer ENT Disorder Treatment Introduction
13.3.4 Pfizer Revenue in ENT Disorder Treatment Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Mylan
13.4.1 Mylan Company Details
13.4.2 Mylan Business Overview
13.4.3 Mylan ENT Disorder Treatment Introduction
13.4.4 Mylan Revenue in ENT Disorder Treatment Business (2015-2020)
13.4.5 Mylan Recent Development
13.5 Teva Pharmaceutical
13.5.1 Teva Pharmaceutical Company Details
13.5.2 Teva Pharmaceutical Business Overview
13.5.3 Teva Pharmaceutical ENT Disorder Treatment Introduction
13.5.4 Teva Pharmaceutical Revenue in ENT Disorder Treatment Business (2015-2020)
13.5.5 Teva Pharmaceutical Recent Development
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Details
13.6.2 GlaxoSmithKline Business Overview
13.6.3 GlaxoSmithKline ENT Disorder Treatment Introduction
13.6.4 GlaxoSmithKline Revenue in ENT Disorder Treatment Business (2015-2020)
13.6.5 GlaxoSmithKline Recent Development
13.7 Otonomy
13.7.1 Otonomy Company Details
13.7.2 Otonomy Business Overview
13.7.3 Otonomy ENT Disorder Treatment Introduction
13.7.4 Otonomy Revenue in ENT Disorder Treatment Business (2015-2020)
13.7.5 Otonomy Recent Development
13.8 Merck
13.8.1 Merck Company Details
13.8.2 Merck Business Overview
13.8.3 Merck ENT Disorder Treatment Introduction
13.8.4 Merck Revenue in ENT Disorder Treatment Business (2015-2020)
13.8.5 Merck Recent Development
13.9 Reddy’s
13.9.1 Reddy’s Company Details
13.9.2 Reddy’s Business Overview
13.9.3 Reddy’s ENT Disorder Treatment Introduction
13.9.4 Reddy’s Revenue in ENT Disorder Treatment Business (2015-2020)
13.9.5 Reddy’s Recent Development
13.10 Allergen
13.10.1 Allergen Company Details
13.10.2 Allergen Business Overview
13.10.3 Allergen ENT Disorder Treatment Introduction
13.10.4 Allergen Revenue in ENT Disorder Treatment Business (2015-2020)
13.10.5 Allergen Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. ENT Disorder Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by ENT Disorder Treatment Revenue
Table 3. Ranking of Global Top ENT Disorder Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global ENT Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tonsillitis
Table 6. Key Players of Ear Infections
Table 7. Key Players of Sinus Infections
Table 8. Key Players of Sleep Apnea
Table 9. Global ENT Disorder Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global ENT Disorder Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global ENT Disorder Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global ENT Disorder Treatment Market Share by Regions (2015-2020)
Table 13. Global ENT Disorder Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global ENT Disorder Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. ENT Disorder Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key ENT Disorder Treatment Players
Table 20. Global ENT Disorder Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global ENT Disorder Treatment Market Share by Players (2015-2020)
Table 22. Global Top ENT Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ENT Disorder Treatment as of 2019)
Table 23. Global ENT Disorder Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players ENT Disorder Treatment Product Solution and Service
Table 26. Date of Enter into ENT Disorder Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global ENT Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global ENT Disorder Treatment Market Size Share by Type (2015-2020)
Table 30. Global ENT Disorder Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global ENT Disorder Treatment Market Size Share by Application (2015-2020)
Table 32. Global ENT Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global ENT Disorder Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players ENT Disorder Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players ENT Disorder Treatment Market Share (2019-2020)
Table 36. North America ENT Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America ENT Disorder Treatment Market Share by Type (2015-2020)
Table 38. North America ENT Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America ENT Disorder Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players ENT Disorder Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players ENT Disorder Treatment Market Share (2019-2020)
Table 42. Europe ENT Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe ENT Disorder Treatment Market Share by Type (2015-2020)
Table 44. Europe ENT Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe ENT Disorder Treatment Market Share by Application (2015-2020)
Table 46. China Key Players ENT Disorder Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players ENT Disorder Treatment Market Share (2019-2020)
Table 48. China ENT Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China ENT Disorder Treatment Market Share by Type (2015-2020)
Table 50. China ENT Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China ENT Disorder Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players ENT Disorder Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players ENT Disorder Treatment Market Share (2019-2020)
Table 54. Japan ENT Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan ENT Disorder Treatment Market Share by Type (2015-2020)
Table 56. Japan ENT Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan ENT Disorder Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players ENT Disorder Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players ENT Disorder Treatment Market Share (2019-2020)
Table 60. Southeast Asia ENT Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia ENT Disorder Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia ENT Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia ENT Disorder Treatment Market Share by Application (2015-2020)
Table 64. India Key Players ENT Disorder Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players ENT Disorder Treatment Market Share (2019-2020)
Table 66. India ENT Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India ENT Disorder Treatment Market Share by Type (2015-2020)
Table 68. India ENT Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India ENT Disorder Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players ENT Disorder Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players ENT Disorder Treatment Market Share (2019-2020)
Table 72. Central & South America ENT Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America ENT Disorder Treatment Market Share by Type (2015-2020)
Table 74. Central & South America ENT Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America ENT Disorder Treatment Market Share by Application (2015-2020)
Table 76. AstraZeneca Company Details
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Product
Table 79. AstraZeneca Revenue in ENT Disorder Treatment Business (2015-2020) (Million US$)
Table 80. AstraZeneca Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Product
Table 84. Novartis Revenue in ENT Disorder Treatment Business (2015-2020) (Million US$)
Table 85. Novartis Recent Development
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Product
Table 89. Pfizer Revenue in ENT Disorder Treatment Business (2015-2020) (Million US$)
Table 90. Pfizer Recent Development
Table 91. Mylan Company Details
Table 92. Mylan Business Overview
Table 93. Mylan Product
Table 94. Mylan Revenue in ENT Disorder Treatment Business (2015-2020) (Million US$)
Table 95. Mylan Recent Development
Table 96. Teva Pharmaceutical Company Details
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical Product
Table 99. Teva Pharmaceutical Revenue in ENT Disorder Treatment Business (2015-2020) (Million US$)
Table 100. Teva Pharmaceutical Recent Development
Table 101. GlaxoSmithKline Company Details
Table 102. GlaxoSmithKline Business Overview
Table 103. GlaxoSmithKline Product
Table 104. GlaxoSmithKline Revenue in ENT Disorder Treatment Business (2015-2020) (Million US$)
Table 105. GlaxoSmithKline Recent Development
Table 106. Otonomy Company Details
Table 107. Otonomy Business Overview
Table 108. Otonomy Product
Table 109. Otonomy Revenue in ENT Disorder Treatment Business (2015-2020) (Million US$)
Table 110. Otonomy Recent Development
Table 111. Merck Business Overview
Table 112. Merck Product
Table 113. Merck Company Details
Table 114. Merck Revenue in ENT Disorder Treatment Business (2015-2020) (Million US$)
Table 115. Merck Recent Development
Table 116. Reddy’s Company Details
Table 117. Reddy’s Business Overview
Table 118. Reddy’s Product
Table 119. Reddy’s Revenue in ENT Disorder Treatment Business (2015-2020) (Million US$)
Table 120. Reddy’s Recent Development
Table 121. Allergen Company Details
Table 122. Allergen Business Overview
Table 123. Allergen Product
Table 124. Allergen Revenue in ENT Disorder Treatment Business (2015-2020) (Million US$)
Table 125. Allergen Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ENT Disorder Treatment Market Share by Type: 2020 VS 2026
Figure 2. Tonsillitis Features
Figure 3. Ear Infections Features
Figure 4. Sinus Infections Features
Figure 5. Sleep Apnea Features
Figure 6. Global ENT Disorder Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Home Care Settings Case Studies
Figure 11. Others Case Studies
Figure 12. ENT Disorder Treatment Report Years Considered
Figure 13. Global ENT Disorder Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global ENT Disorder Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global ENT Disorder Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global ENT Disorder Treatment Market Share by Players in 2019
Figure 18. Global Top ENT Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ENT Disorder Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by ENT Disorder Treatment Revenue in 2019
Figure 20. North America ENT Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe ENT Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China ENT Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan ENT Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia ENT Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India ENT Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America ENT Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed

以下、関連資料のご紹介
  • 脂質異常症治療の世界市場（～2026年）
    Global Lipid Disorder Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY12520 2020年11月25日 92Pages
    当調査資料は脂質異常症治療のグローバル市場について調査・分析したレポートです。種類別（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他薬剤）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...
  • 甲状腺障害治療の世界市場（～2026年）
    Global Thyroid Gland Disorder Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04853 2020年11月20日 93Pages
    当調査資料は甲状腺障害治療のグローバル市場について調査・分析したレポートです。種類別（甲状腺機能亢進症、甲状腺機能低下症、その他）市場規模、用途別（男性、女性）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラ...
  • 季節性情動障害治療の世界市場（～2026年）
    Global Seasonal Affective Disorder Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04565 2020年11月20日 90Pages
    当調査資料は季節性情動障害治療のグローバル市場について調査・分析したレポートです。種類別（光線療法（光線療法）、薬物、心理療法、カウンセリング、その他）市場規模、用途別（病院、診療所、医学研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロ...
  • 自閉症スペクトラム障害（ASD）治療の世界市場（～2026年）
    Global Autism Spectrum Disorder (ASD) Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY10928 2020年11月25日 94Pages
    当調査資料は自閉症スペクトラム障害（ASD）治療のグローバル市場について調査・分析したレポートです。種類別（自閉症、アスペルガー症候群、広汎性発達障害、小児期崩壊性障害）市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア...
  • 強迫性障害治療の世界市場（～2026年）
    Global Obsessive-Compulsive Disorder Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04031 2020年11月20日 90Pages
    当調査資料は強迫性障害治療のグローバル市場について調査・分析したレポートです。種類別（ADX-88178、ビトペルチン、CR-5542、ジプラグラントIR、マレイン酸フルボキサミン、マボグルラント、その他）市場規模、用途別（クリニック、病院、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロ...
  • 認知症・運動障害治療の世界市場（～2026年）
    Global Dementia and Movement Disorder Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11592 2020年11月25日 94Pages
    当調査資料は認知症・運動障害治療のグローバル市場について調査・分析したレポートです。種類別（MAO阻害剤（モノアミン酸化酵素）、AChE阻害剤（アセチルコリンエステラーゼ）、グルタミン酸阻害剤）市場規模、用途別（ブランド薬品、ジェネリック薬品）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ...
  • 胎児性アルコールスペクトラム障害（FASD）治療の世界市場（～2026年）
    Global Fetal Alcohol Spectrum Disorder Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11930 2020年11月25日 97Pages
    当調査資料は胎児性アルコールスペクトラム障害（FASD）治療のグローバル市場について調査・分析したレポートです。種類別（抗うつ薬、覚醒剤、神経弛緩薬、抗不安薬）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリ...
  • 慢性うつ病性人格障害治療の世界市場（～2026年）
    Global Chronic Depressive Personality Disorder Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11360 2020年11月25日 96Pages
    当調査資料は慢性うつ病性人格障害治療のグローバル市場について調査・分析したレポートです。種類別（選択的セロトニン再取り込み阻害薬、三環系抗うつ薬、ノルエピネフリン再取り込み阻害薬、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、...
  • 色素沈着障害治療の世界市場（～2026年）
    Global Pigmentation Disorder Therapeutic Market Size, Status and Forecast 2020-2026
    MRC2-11QY04274 2020年11月20日 91Pages
    当調査資料は色素沈着障害治療のグローバル市場について調査・分析したレポートです。種類別（薬物療法（外用薬、ハイドロキノン、L-アスコルビン酸、その他）、美容治療（ケミカルピーリング、レーザー治療、植皮、その他））市場規模、用途別（皮膚科クリニック、ドラッグストア・化粧品店、エステティッククリニック、...
  • 睡眠障害治療薬の世界市場（～2026年）
    Global Sleep Disorder Therapeutics Market Size, Status and Forecast 2020-2026
    MRC2-11QY04641 2020年11月20日 96Pages
    当調査資料は睡眠障害治療薬のグローバル市場について調査・分析したレポートです。種類別（不眠症、過度睡眠、睡眠障害）市場規模、用途別（病院薬局、オンライン薬局、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オ...
  • 脂質異常症治療の世界市場（～2026年）脂質異常症治療の世界市場（～2026年） Lipid disorder means the people high blood levels of low-density lipoprotein (LDL) cholesterol, fats called triglycerides,. Several biopharma companies are focusing on developing effective solutions for treating lipid disorders. Companies involved in lipid disorder treatment market include Teva Phar…
  • 季節性情動障害治療の世界市場（～2026年）季節性情動障害治療の世界市場（～2026年） Seasonal Affective Disorder is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people between th…
  • 甲状腺障害治療の世界市場（～2026年）甲状腺障害治療の世界市場（～2026年） Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect major…
  • 自閉症スペクトラム障害（ASD）治療の世界市場（～2026年）自閉症スペクトラム障害（ASD）治療の世界市場（～2026年） Autism spectrum disorder (ASD) refers to a group of complex neurodevelopment disorders characterized by repetitive and characteristic patterns of behavior and difficulties with social communication and interaction. According to CDC statistics, 1 in every 68 children suffers with autism. Innovative d…
  • 強迫性障害治療の世界市場（～2026年）強迫性障害治療の世界市場（～2026年） Market Analysis and Insights: Global Obsessive-Compulsive Disorder Treatment Market The global Obsessive-Compulsive Disorder Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Obsessive-Compulsive Disorder Treat…